COMPANY OVERVIEW

None

---

LOCATION

---

THERAPEUTIC AREAS

---

WEBSITE

https://excellthera.com/

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

PRESS RELEASES

Nov 15, 2022

ExCellThera announces completion of Phase 2 clinical trials for UM171-expanded cell therapy in high-risk blood cancers

Nov 8, 2022

ExCellThera announces 100th patient treated with UM171-expanded cell therapy

Nov 4, 2022

ExCellThera announces oral presentation of new data on UM171-expanded cell therapy at the ASH Annual Meeting

Jun 17, 2022

ExCellThera announces submission of Drug Master File for UM171

Apr 13, 2022

ExCellThera announces new publication showing its ECT-001 cell therapy improves transplant access for all patients

For More Press Releases

---